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Copyright © 2008 JCBN Summary Accumulating data demonstrated that hypercholesterolemia and oxidative stress
play an important role in the development of atherosclerosis. In the present study, a protective
activity of alpha-lipoic acid; a metabolic antioxidant in hypercholesterolemic-induced animals
was investigated. Eighteen adult male New Zealand White (NZW) rabbit were segregated into
three groups labelled as group N, HCD and ALA (n = 6). Group N (normal control) was fed
with normal chow, the rest (HCD and ALA) were fed with 100 g/head/day of 1% cholesterol
rich diet to induce hypercholesterolemia. Four point two mg/body weight of alpha lipoic acid
was concomintantly supplemented to the ALA group. Drinking water was given ad-libitum.
The study was designed for 10 weeks. Blood sampling was taken from the ear lobe vein at the
beginning, week 5 and week 10. Plasma was prepared for lipid profile estimation and micro-
somal lipid peroxidation index indicated with malondialdehyde (MDA) formation. At the end
of the experiment, the animals were sacrificed and the aorta were excised for intimal lesion
analysis. The plasma total cholesterol (TC) and low density lipoprotein (LDL) levels were
found to be significantly low in ALA group compared to that of the HCD group (p<0.05).
Similarly, low level of MDA (p<0.05) in ALA group was observed compared to that of the
HCD group showing a significant reduction of lipid peroxidation activity. Histomorphometric
intimal lesion analysis of the aorta showing less of atheromatous plaque formation in alpha
lipoic acid supplemented group (p<0.05) compared to HCD group. These findings suggested
that alpha lipoic acid posses a dual lipid lowering and anti-atherosclerotic properties indicated
with low plasma TC and LDL levels and reduction of athero-lesion formation in hyper-
cholesterolemic-induced rabbits.
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Introduction
The relationship between hypercholesterolemia with the
prevalence of cardiovascular diseases (CVD) has been well
documented. Increased in plasma low density lipoprotein
(LDL) concentration has been associated with the suscepti-
bility of developing atherosclerosis [1–2]. Although precise
mechanism of atherogenesis still need further investigation,
oxidative modification of LDL is considered to be an essen-
tial process in the activation of the inflammatory pathway
leading to formation of atheromatous plaque in the intimal
layer of the artery [3–5]. In contrast to the adverse effects of
an elevation of LDL, the concentration of high density lipo-
protein (HDL) correlates inversely with atherosclerosis
development [2,  6]. Increased oxidative stress, resulting
from both increased reactive oxygen species (ROS) produc-
tion appears to play an important role in the chronic inflam-
matory responses to hypercholesterolemia and atheroscle-
rosis [1, 6–9]. Therefore, apart from hypocholesterolemic
drug intervention in reducing blood cholesterol level, the
prophylaxis of atherosclerosis using antioxidant therapy has
been extensively evaluated in animal experiments [7, 9, 10].
Alpha lipoic acid (ALA), also known as 1,2-dithiolane-3-
pentanoic acid, 1,2-dithiolane-3-valeric acid or 6,8-thioctic
acid has generated considerable clinical interest as a cellular
thiol-replenishing and redox-modulating agent [11]. Bio-
logically, alpha lipoic acid functions as a cofactor of oxida-
tive decarboxylation reactions in glucose metabolism to
yield energy [12]. It has been used for a long time in the
western world to treat complications associated with
diabetes [13]. To carry out this function, the disulfide group
of the lipoic acid dithiolane ring is reduced to its dithiol
form, dihydrolipoic acid, DHLA. Current findings suggest
that alpha lipoic acid not only acts as a cofactor in glucose
metabolism, but may also acts as an antioxidant in vitro and
in vivo [14]. In vitro experiments have shown that both ALA
and DHLA are potent scavengers of reactive oxygen species.
Alpha lipoic acid quenches singlet oxygen, hydroxyl radical
and hypochlorus acid [15] while DHLA scavenges hydroxyl
radicals, hypochlorus acid, superoxide anions radicals and
peroxyl radicals [16].
The observations of ALA as an antioxidant in vitro and in
vivo were previously based on hyperglycaemic ambience
[13, 17, 18]. However, until now, no experimental design has
addressed the question as to whether ALA could work in
atherosclerotic atmosphere in vivo thus preventing the
proliferation and propagation of this degenerative disease.
Lipid peroxidation, the oxidative deterioration of the
polyunsaturated fatty acids (PUFA), leads to the formation
of hydroperoxides, short-chain aldehydes, ketones and other
oxygenated compounds. This process is considered respon-
sible for the development of various diseases like atheroscle-
rosis [13], diabetes [19], cancer [20] and may be one of the
main contributing factor towards aging [21]. In the present
study, we sought to determine whether ALA is able to exert
its antioxidative effect and alter blood lipid levels in
atherosclerosis-induced animals.
Materials and Methods
Experimental animals
Eighteen three month-old male New Zealand White
(NZW) rabbits with an average body weight of 2.2–2.8 kg
were procured from the central animal house of the Faculty
Medicine and Health Science, UPM. The animals were
placed in individual cages and acclimatized under room
temperature and humidity (28 ± 2°C; relative humidity 60–
70%) with regular light/dark cycle and free access to food
and water for one week before use. Following acclimatiza-
tion, the animals were segregated into three groups and fed
with of the following: 1. Normal control group (N) was
given 100 g/head/day of normal rabbit chow (Golden Hope,
Malaysia), 2. Hypercholesterolemic-induced group (HCD)
was given 100 g/head/day of 1% cholesterol-rich diet (ICN
Biomedical, California) and 3. Alpha-lipoic acid-treated
group (ALA) was given 100 g/head/day of 1% cholesterol-
rich diet concomitantly with 4.2 g/kg/day of alpha-lipoic
acid (Sigma Chemicals). Alpha-lipoic acid was supple-
mented by oral gavage daily. The dose of alpha-lipoic acid
used in this study was based from previous work (data not
shown). Drinking water was given ad libitum. The study was
designed for 10 weeks. Blood sampling were taken prior to
treatment (w = 0), at week five (w = 5) and week 10
(w = 10). Twenty five ml of ear lobe venous blood samples
were drawn into EDTA coated tubes, placed in a transport
ice bucket and were centrifuged at 3000 rpm in a
refrigerated bench top centrifuge for 10 min at 4°C.
Plasma samples were prepared and analysed for total
cholesterol (TC), low density lipoprotein (LDL), high
density lipoprotein (HDL), triglycerides (TG) and micro-
somal lipid peroxidation indicated by malondialdehyde
estimation. In week ten, the animals were sacrificed by
exsanguination after withdrawing the same volume of blood
samples from ear vein as previously described and the
plasma sample obtained were aliquoted and kept in −70°C
for a maximum of 7 days before analyses. Following
exsanguination, the whole aorta were excised for histo-
mormetric intimal lesion analyses. All experimental proce-
dures on the animals were performed in accordance with
protocols approved by the Animal Care & Use Committee,
Faculty of Medicine and Health Sciences, Universiti Putra
Malaysia.
Biochemical analyses
Lipid profiles estimation. Lipid profiles observed are
the total cholesterol (TC), triglycerides (TG), high-densityZ. Amom et al.
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lipoprotein (HDL) and low-density lipoprotein (LDL).
Samples were processed following protocols provided by
the manufacturer of the commercial kit (Sigma Chemicals)
and were analysed spectrophotometrically on Hitachi
Chemistry Analyzer.
Microsomal lipid peroxidation and protein estimation.
Plasma samples obtained were used to study lipid peroxi-
dation in vivo. Malondialdehyde (MDA) as thiobarbituric
acid reactive substance was measured at 532 nm spectro-
photometrically (Bolkent et al., 2005) whereas the protein
concentration was determined by Biuret’s method as pre-
viously described [22].
Quantification of aortic atheroslerosis. The full length
of the aorta from the ascending to the common iliac were
isolated immediately after exsanguination and washed with
iced-cold normal saline to remove debris and blood clot. The
aorta was stripped from excess adventitial and fat tissues. A
longitudinal section was made on the aorta using a scissor to
exposed the lumen. The tissue was pinned on a wooden
board with the luminal surface is exposed above following
immersion in 10% formalin for 24 h. After the incubation
period, the tissue was rinsed with 70% ethanol followed by
immersion in Sudan IV staining (Sigma Chemicals) for
15 min to identify lipid containing atheromatous plaque. The
tissue was rinsed with tap water to remove excess staining
and the luminal surface was photographed using a single lens
reflex digital camera (Canon EOS 300D, Japan). The intimal
lesion area was measured further using a computerised
image analyser system and area ratio was calculated as area
of lesion/area of intimal surface. The image analysis system
consisted of a Macintosh lix computer (Apple) equipped
with a Frame Grabber Card (Quick Capture, Data Transla-
tion), a Sony high-resolution video camera, and Trinitron
Super Mac 21 inch color monitor.
Statistical analysis. Sample were analysed in triplicate.
All data were expressed as mean ± standard deviation.
Statistical analysis was done by one-way ANOVA using the
SIGMAStat version 2.01 computer software. Tukey post-tests
were performed for multiple group comparison. In all cases,
statistical significance was set at p<0.05.
Results
Plasma lipids analysis
The results of the plasma lipid profiles are shown in
Table 1. All lipid fractions at w = 0 demonstrated a low basal
level in all groups.
Total cholesterol (TC). When fed with 1% high choles-
terol diet, rabbits in both HCD and ALA groups developed
marked hypercholesterolemia although there was no signifi-
cant different in plasma HCD and ALA at w = 5. Both of
these groups (HCD and ALA) exhibit hypercholesterolemia
at week 5 (both p<0.05) with 3.8 and 4.8 times higher than
that of the N group in the same time period. The level of TC
in HCD group further increased significantly (p<0.05) at
w = 10 with 1.9 times higher compared at w = 5 and 4.98
times higher than N group at w = 10. Supplementation of
4.2 mg/kg of alpha lipoic acid daily was found to be able to
sustain the plasma TC level in ALA group with no signifi-
cant different at w = 5 and w = 10 respectively. Infact, TC
level in ALA group was shown to be at low level signifi-
cantly (p<0.05) compared to HCD group at w = 10 with 35%
reduction.
High density lipoprotein (HDL). The level of HDL in both
of N and ALA groups (inter and intra group) do not changed
significantly throughout the experimental period. The level
of HDL in N group at the beginning of the experiment was
found to be lower compared to the other groups. However, it
is presumed to be normal with no treatment given and do not
affect the overall HDL analysis. The HDL level in HCD
group was found to be lower significantly (p<0.05) at w = 5
and w = 10 with 1.2 and 1.3 times reduction compared to
that of at w = 0. The level of HDL in alpha lipoic acid
supplemented group however remained constantly high in
w = 10 (1.63 mmol/l) resembling the level of which at w = 0
(1.66 mmol/l) and the level is significantly higher (p<0.05)
compared to that of HCD and N group respectively in the
same time period.
Low density lipoprotein (LDL). The plasma LDL level
was initially similar in all groups at the beginning of the
experiment (w = 0) (mean of basal plasma LDL of three
groups was 1.51 ± 0.23 mmol/l), but were significantly
higher at w = 5 in HCD and ALA groups, compared to the
Table 1. Blood lipids (mmol/l) and the ratio of TCHOL and HDL of animals prior to the experiment, week 5 and at week 10
(mean ± standard deviation, N = control, high cholesterol diet = 1% high cholesterol diet, ALA = 1% high cholesterol
diet + 4.2 mg/kg alpha lipoic acid)
TCHOL HDL TG LDL TC:HDL ratio
N HCD ALA N HCD ALA N HCD ALA N HCD ALA N HCD ALA
Week zero 
(w0) 4.60 ± 0.22 3.83 ± 0.57 4.31 ± 0.32 1.23 ± 0.09 1.68 ± 0.18 1.66 ± 0.11 4.31 ± 0.22 4.57 ± 0.43 4.80 ± 0.35 1.38 ± 0.06 1.76 ± 1.03 1.35 ± 0.03 3.74 ± 0.11 2.28 ± 0.24 2.61 ± 0.22
Week 5 
(w5) 4.55 ± 0.34 17.29 ± 4.05 22.22 ± 2.30 1.40 ± 0.17 1.39 ± 0.19 1.70 ± 0.09 4.12 ± 0.12 4.77 ± 0.36 4.40 ± 0.22 1.13 ± 0.06 14.54 ± 4.06 17.39 ± 0.96 3.27 ± 0.16 12.79 ± 3.78 3.27 ± 2.08
Week 10 
(w10) 6.65 ± 0.10 33.16 ± 4.03 21.52 ± 2.80 1.33 ± 0.08 1.32 ± 0.12 1.63 ± 0.11 4.14 ± 0.09 4.86 ± 0.32 4.65 ± 0.28 2.44 ± 0.08 30.43 ± 3.98 15.72 ± 0.74 4.26 ± 0.20 25.65 ± 4.45 13.23 ± 0.92Lipid Lowering Effect of Alpha-Lipoic Acid
Vol. 43, No. 2, 2008
91
control group which remained at low level. The level of
plasma LDL in HCD group was found to increased further
significantly at w = 10 with 2 times increment from w = 5
level (p<0.05). The level of LDL in ALA group however
was found to be not significantly difference at w = 10
compared to its level at w = 5. Infact, the level of LDL in
alpha lipoic supplemented group at w = 10 was significantly
low with almost two times lower than that of HCD group in
the same experimental period.
Triglycerides (TG). No significant difference of plasma
TG level was observed in all groups throughout the experi-
mental period. However, there is a pattern of increased TG
level in HCD group and reduced TG level in ALA group
both at w = 5 and w = 10.
TC: HDL ratio. The value of TC:HDL ratio has been used
as an indicator of lipid lowering property. In this experiment,
the ALA group showing significantly lower TC: HDL ratio
both at w = 5 and w = 10 (p<0.05) compared to that of the
HCD group. No significant different was obtained in ALA
group at w = 5 and w = 10 respectively. The 1% cholesterol
load to NZW rabbits was found to increase TC level signifi-
cantly in both HCD and ALA groups but the lower TC: HDL
ratio observed in the alpha lipoic acid treatment group
suggested that supplementation of alpha lipoic acid may
have possibly facilitated the hepatic HDL biosynthesis in
vivo than the overall total cholesterol concentration.
Microsomal lipid peroxidation
The concentration of tiobarbituric acid reactive substance
(TBARS) as microsomal lipid peroxidation marker is shown
in Fig. 1. No significant different was observed in the level
of TBARS in N and HCD group at w = 5, but was
significantly lower (p<0.05) in ALA group in the same week
compared to its control at w = 0 and also to HCD at w = 5.
However TBARS level in ALA group was increased at
w = 10. Nevertheless, the increment was considered small
and still at low pace compared to its control at w = 0
(p<0.05). The level of TBARS in HCD group showed to be
highest throughout the experimental period, indicating that
1% cholesterol load to NZW rabbit for 10 weeks was able to
cause marked hypercholesterolemia and allowing micro-
somal lipid peroxidation process to be overwhelming in vivo.
Aortic intimal lesion analysis
The histomorphometric analysis of the development of
aortic intimal lesion is shown in Fig. 2A. This study demon-
strated that high cholesterol diet could generate not only
hypercholesterolemia, but also proceeded to the formation
of atheromatous plaque in the luminal surface of the aorta.
However, the group of high cholesterol diet supplemented
with ALA showed a significatly lesser athero-formation in
the aortic lumen compared to that of the group which was
not given ALA supplementation. The percentage area of the
lesion was shown to be lower in the alpha lipoic acid
supplemented group (p<0.05), compared to that of the HCD
group and no significant difference was found between ALA
and the control (N) group. There is also minute athero-
slerotic plaque formation was observed in the intimal layer
of the aorta of the N group with less than 1% whereas the
distribution of the developed lesions was found to be more at
the aortic arch with less at the abdominal region in all groups
(see arrow in Fig. 2B).
Discussion
In this experiment, 1% cholesterol load to the animals
Fig. 1. The microsomal lipid peroxidation indicated by malondialdehyde (MDA) level in plasma of normal control group (N), high
cholesterol diet (HCD) and high cholesterol diet + alpha lipoic acid group (ALA) at the respective week of treatment. Data are
expressed as mean ± SD, n = 6. a p<0.05 compare to ALA at week zero (ALAw = 0), b p<0.05 compare to HCDw = 5, c p<0.05
compare to Nw = 10.Z. Amom et al.
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generated hypercholesterolemia in the model used. Studies
both in animals and human have clearly demonstrated that
prolonged high cholesterol concentration in the circulating
blood have a positive correlation on developing atheroscle-
rosis [4, 18, 19, 23]. Results from the plasma lipid profiles of
1% high cholesterol fed animals for 10 weeks showed
concentration of plasma TC and LDL respectively has
increased 4.5 and 8.3 times higher in w = 5 and further
increased 8.7 and 17.3 times in w = 10 compared to the level
before the experiment, whereas HDL was decreased. These
finding were similar to findings from previous studies [7,
18]. These changes are associated with a phenomenon that
excessive load of cholesterol to the liver above the accept-
able level of its normal process causes the system to be
unable in metabolising the lipids resulting in high
cholesterol return in the circulating blood [24–25].
The value of TC: HDL ratio has been used as an indicator
of lipid lowering property. In this experiment, the ALA
group showed significantly (p<0.5) lower TC: HDL ratio at
both w = 5 and w = 10 with 4 and 2 times reduction
respectively in the values when compared to the HCD group.
The 1% cholesterol load to NZW rabbits was find to increase
the TC level significantly in both HCD and ALA groups
but the low TC: HDL ratio observed in the ALA group
indicating that supplementation of alpha-lipoic acid may have
possibly facilitated the hepatic HDL biosynthesis in vivo.
In the present study, when Atherogenic Index in Plasma
(AIP) was calculated (log TG/HDL), it was found that there
were no significant differences in the value of AIP between
ALA (0.41 and 0.46) and N (0.47 and 0.49) at both w = 5
and w = 10 respectively, which suggest the antiatherogenic
property of alpha-lipoic acid to the animals. Interestingly,
the value of AIP in ALA supplemented group also remained
relatively stable throughout the study period (0.41–0.46).
The use of AIP is a useful predictor of coronary risk
potentials as it gives indirect measure of lipoproteins (LDL
and HDL) particle size. The significantly lower AIP in both
N and ALA groups relative to the HCD group (0.5–0.6 at
Fig. 2. A. Histomorphometric analysis of intimal lesion area in alpha lipoic acid treated group (ALA) showing a less progression of
atheromatous plaque formation compared to the group with high cholesterol diet only (HCD). Data are expressed as
mean ± SD, n = 6. *p<0.05 compare to atherosclerotic group.
B. The macroscopy observation of the atheromatous plaque formation on the luminal surface of the aorta stained with Sudan IV
from the group of high cholesterol diet only (a), the high cholesterol diet + alpha lipoic acid (b) and the normal control group
(c). Arrow indicated the presence of atheroma.Lipid Lowering Effect of Alpha-Lipoic Acid
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w = 5 and w = 10 respectively) observed in this study
correspond well to the inverse correlation of the LDL size
and AIP values analyzed from 35 cohorts of 1433 subjects
with various risk of atherosclerosis and a cohort of 35
normal subjects [26].
In the present study, we also found that supplementation
of alpha lipoic acid in high cholesterol fed animals could
inhibit the progression of atherosclerosis. The formation of
atheromatous plaque in the alpha lipoic acid treated group
was found to be significantly lower compare to that of the
non-treated group (HCD). This data may provide to a new
lipoate activity in vivo. The inhibition effect by alpha lipoic
acid in atherogenesis might be attributable partly to its hypo-
cholesterolemic property. Previous study indicated that the
related metabolic functions of alpha lipoic acid is on its role
in blood glucose disposal [13] through the glucose-
metabolizing enzymes, prostaglandin dehydrogenase and
alpha keto-glutarate dehydrogenase eventhough some
researchers suspects a more direct role in cellular glucose
uptake at the cellular membrane [27]. However, the involve-
ment of this substance in cardiovasular related diseases and
hypercholesterolemia have not been studied. Nevertheless,
the prophylaxis of atherosclerosis using antioxidant therapy
has been extensively evaluated in animal experiments.
Oxidative stress is one of the causative factors that link
hypercholesterolemia with the pathogenesis of atheroscle-
rosis [4, 6, 28]. Alpha lipoic acid through its reduced form
DHLA exhibits a protective measure against free radicals
activity eventhough its precise mechanism is still yet to be
discovered. In our study, the TBARS level indicated by
MDA concentration at w = 5 was significantly lower in the
alpha lipoic acid treated group compared to that of the
untreated group (HCD) indicating that apart of its hypo-
cholesterolemic effect, alpha lipoic acid also may act as
antioxidant. This findings was parallel to previous reports
suggesting that alpha lipoic acid would be a potent meta-
bolic antioxidant source to quench free radicals in vitro and
in vivo [21, 29–30]. Sen and coworkers [27] reported that
alpha lipoic acid analogue have a positively charged in
physiologic pH. DHLA is a potent sulfhydryl reductant;
redox potential of the DHLA: ALA couple is −0.32 V
(compared to −0.24 V for the glutatione:oxidized glutatione
couple) [31]. This low redox potential may enable DHLA to
easily donate its electron to electron-deprived molecules
subsequently neutralized free radical activity. Studies with
human Jurkat T cells have shown that when added to the
culture medium, lipoate readily enters the cell where it is
reduced to DHLA and rapidly efflux into the culture medium
[16]. The concentration of MDA increased in w = 10. This
phenemenon was speculated due to high retention of
cholesterol, particularly the LDL in the plasma that in turn
exposing them to free radical attacks. It is well known that
high cholesterol diet induces the overproduction of reactive
oxygen species (ROS) which could initiate lipid peroxida-
tion (LPO) [14, 32]. Supplementation of alpha lipoic acid
has shown to have favourable effect for the first five week of
treatment, however, excessive cholesterol level in blood due
to continual cholesterol load may possibly have over-
shadowed the existing effect in the subsequent period. This
study also reveals that prolonged intake of high cholesterol
diet may cause retention of TC and LDL therefore exposing
them to free radical attacks even with supplementation of
exogenus antioxidant. The extra high concentration of
cholesterol may accumulated in the hepato-biliary system
resulting in relative high blood LDL. Reduction of TC and
LDL would heavily depend on the cholesterol concentration
in the diet.
This experiment suggest that alpha lipoic acid supple-
mentation may increase lipid and lipoprotein regulation. The
mechanism on how alpha lipoic acid able to reduce TC and
LDL concentration is unknown, but probably via lipoprotein
lipase (LPL) activity or through cholesterol metabolisme by
the liver [32]. Chiba and co-worker reported LPL activity
and HDL level is increased in cholesterol fed NZW rabbit
after administration of NO-1886 [33]. Alpha lipoic acid
probably capable to initiate LDL receptor synthesis in the
liver which in turn increase the uptake of cholesterol back to
the hepatic system and increase synthesis of apoprotein A
component (moeity of HDL particles) for reversed
cholesterol transport [14]. With consideration to the dose of
alpha lipoic acid, progression of atherosclerotic disease
probably could be reduced to some extent. Although the
present data do not allow the conclusion that alpha lipoic
acid supplementation could prevent atherosclerosis-free
radical activity, the data are in agreement with a model in
which antioxidant supplementation may contributes to a
reduction of bad cholesterol in the circulatory system.
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